MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,866 | -32.6% | 116,353 | -2.6% | 0.00% | -33.3% |
| Q2 2023 | $2,769 | +48.4% | 119,465 | +48.8% | 0.01% | +20.0% |
| Q1 2023 | $1,866 | +54.7% | 80,306 | -3.4% | 0.01% | +66.7% |
| Q4 2022 | $1,206 | -99.9% | 83,120 | -0.3% | 0.00% | -25.0% |
| Q3 2022 | $1,590,000 | +10.9% | 83,354 | +5.6% | 0.00% | 0.0% |
| Q2 2022 | $1,434,000 | -12.5% | 78,934 | +21.4% | 0.00% | +33.3% |
| Q1 2022 | $1,638,000 | -8.7% | 65,008 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,794,000 | -11.9% | 64,987 | +3.0% | 0.00% | -25.0% |
| Q3 2021 | $2,037,000 | +5.8% | 63,093 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,926,000 | +2.4% | 62,990 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $1,881,000 | +52.8% | 61,783 | -0.8% | 0.00% | +33.3% |
| Q4 2020 | $1,231,000 | +52.4% | 62,253 | +0.5% | 0.00% | +50.0% |
| Q3 2020 | $808,000 | -15.9% | 61,948 | -26.9% | 0.00% | -33.3% |
| Q2 2020 | $961,000 | -20.7% | 84,723 | +0.1% | 0.00% | -25.0% |
| Q1 2020 | $1,212,000 | -24.9% | 84,664 | +42.9% | 0.00% | -20.0% |
| Q4 2019 | $1,613,000 | -4.3% | 59,232 | +0.7% | 0.01% | 0.0% |
| Q3 2019 | $1,685,000 | +5.5% | 58,849 | +2.4% | 0.01% | 0.0% |
| Q2 2019 | $1,597,000 | -15.8% | 57,483 | +0.7% | 0.01% | -16.7% |
| Q1 2019 | $1,896,000 | +23.3% | 57,110 | +8.0% | 0.01% | 0.0% |
| Q4 2018 | $1,538,000 | -98.6% | 52,892 | -97.8% | 0.01% | -98.2% |
| Q3 2018 | $109,137,000 | +2.2% | 2,372,526 | -17.0% | 0.34% | -1.7% |
| Q2 2018 | $106,760,000 | +26.8% | 2,856,846 | +0.3% | 0.35% | +22.1% |
| Q1 2018 | $84,182,000 | -12.8% | 2,848,804 | +1.4% | 0.28% | -11.8% |
| Q4 2017 | $96,524,000 | -5.0% | 2,810,436 | +0.0% | 0.32% | -10.0% |
| Q3 2017 | $101,651,000 | +43.4% | 2,809,600 | +2.5% | 0.36% | +22.1% |
| Q2 2017 | $70,862,000 | +9488.9% | 2,742,340 | +7026.7% | 0.29% | +9700.0% |
| Q1 2017 | $739,000 | -8.3% | 38,480 | +46.1% | 0.00% | -25.0% |
| Q2 2016 | $806,000 | -34.2% | 26,340 | -19.4% | 0.00% | -33.3% |
| Q1 2016 | $1,224,000 | -12.5% | 32,690 | -9.1% | 0.01% | -25.0% |
| Q2 2014 | $1,399,000 | – | 35,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |